Detection of Chemotherapy Induced Peripheral Neuropathy
- Study HIC#:2000028597
- Last Updated:04/28/2024
This study will aim to identify new methods to screen for peripheral neuropathy in routine oncology clinic visits, by comparing survey questions with abnormal examination findings.
Contact Us
For more information about this study, including how to volunteer, contact:
Jaime Rotatori
- Phone Number: 1-203-785-2407
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Eligibility Criteria
Inclusion Criteria:
1. For participation in the survey and specialized examination: Participants will be eligible for inclusion if they have a diagnosis of any non-central nervous system malignancy, their current age is ≥3 years and <18 years, they have received, are currently receiving, or will receive neurotoxic chemotherapy with a vinca alkaloid or platinating agent.
2. For participation biomarker study/additional blood draw: Participants will be eligible for inclusion if they have a diagnosis of any non-central nervous system malignancy, their current age is ≥3 years and <18 years, they have not received prior neurotoxic chemotherapy, they will receive treatment with a vinca alkaloid.
